









Markets
/
Stocks
/
nasdaq-ifrx
/

InflaRx NV

IFRX

View Detailed Chart

0.860USD

-0.045-4.97%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

54.45MMarket Cap

LossP/E TTM



InflaRx NV

0.860

-0.045-4.97%

Overview Company Financials

Financials

Intraday

30m

Today

-4.97%

5 Days

-4.31%

1 Month

+7.18%

6 Months

-64.32%

Year to Date

-65.18%

1 Year

-41.50%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

BUY

Current Rating

4.286

Target Price

398.34%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

InflaRx NV

IFRX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(3)

Buy(0)

Indicators

Sell(4)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.020

Neutral

RSI(14)

46.594

Neutral

STOCH(KDJ)(9,3,3)

44.953

Sell

ATR(14)

0.062

Low Volatility

CCI(14)

15.964

Neutral

Williams %R

60.000

Sell

TRIX(12,20)

0.035

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.879

Sell

MA10

0.871

Sell

MA20

0.868

Sell

MA50

0.913

Sell

MA100

1.115

Sell

MA200

1.578

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.

Ticker SymbolIFRX

CompanyInflaRx NV

CEOProf. Niels C. Riedemann, M.D., Ph.D

Websitehttps://www.inflarx.de/